Ondansetron Orally Disintegrating Tablets
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0018
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 mg tablets in 30-count bottles and 8 mg tablets in 10 and 30-count bottles. This commercial item procurement will utilize FAR Part 12 procedures and establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. The acquisition will be unrestricted and fully competitive, with all sources eligible to submit proposals for agency consideration. Interested parties should contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil for questions or comments. The projected solicitation date is September 2025, though DLA reserves the right to issue the solicitation before or after this timeframe.
This opportunity is designated as "No Set-Aside Used," making it open to all qualified contractors without small business restrictions. The contract structure will be a firm-fixed price requirements-type contract with a one-year base period and four one-year option periods, potentially spanning five years total. Annual usage estimates will be provided in the Schedule of Supplies section when the formal solicitation is released. The contract will operate under FAR 52.216-21 (Requirements) provisions to serve multiple government agencies' pharmaceutical needs. Interested parties are advised to establish automated notifications through the procurement websites to stay informed of any pre-solicitation or solicitation changes, and the formal solicitation will be posted on both the DLA Bid Board System (DIBBS) and Sam.Gov when released.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT). Procurement details follow.
Ondansetron ODT 4 MG Tablet in 30 count bottles.
Ondansetron ODT 8 MG Tablet in 10 and 30 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (445) 737-0713, (Nancy.Fernandez@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
*The Ondansetron HCL Tablets will be solicited in a separate acquisition.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Ondansetron Orally Disintegrating Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity